B-CELL LYMPHOPROLIFERATIVE DISORDER
Clinical trials for B-CELL LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancer: pacritinib trial opens
Disease control Recruiting nowThis study tests a drug called pacritinib in 30 people with Waldenström macroglobulinemia whose cancer returned or did not respond to prior treatment. The goal is to see if the drug can shrink tumors and improve symptoms. Participants take the drug by mouth and are monitored for …
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New antibody treatment tested for rare blood cancer
Disease control Recruiting nowThis study is testing whether an antibody drug called epcoritamab can help control Waldenstrom Macroglobulinemia, a rare blood cancer, in patients who have already received previous treatments. The trial will enroll 20 participants to measure how well their cancer responds to thi…
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC